Safety Alert for Placental growth factor - Delfia Xpress PIGF kit, record 10298910109, hazard class II, lots 637790

According to Agência Nacional de Vigilância Sanitária (ANVISA), this safety alert involved a device in Brazil that was produced by PerkinElmer do Brasil Ltda.; Wallac Ou.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event ID
    1645
  • Date
    2015-07-22
  • Event Country
  • Event Source
    ANVISA
  • Event Source URL
  • Notes / Alerts
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Extra notes in the data
    According to the instructions for use the results should only be reported if the values ​​are within the range defined as acceptable. That is, incorrect results should not be reported to patients. The associated risk is due to delays in the screening of patients for pre-eclampsia and Down's syndrome in the first trimester.
  • Reason
    Problem related to the stability of lot 637341 of pigf calibrators of the delphia pigf kits (6007-0010, 6007-000 and 6007-002c). the problem is limited to a batch of the pigf calibrators, which is included in the described pigf kit lots. due to the stability problem, there is a tendency to decrease the signal level measured in the calibrators to 20%.
  • Action
    The company that holds the registration guides the immediate discontinuation in the use of the DELFIA Xpress PIGF kit lots highlighted in this field action. The kits should be destroyed. It is requested the analysis of the PIGF control values ​​for the enumerated lots, complete verification. In case QC controls are within acceptable range, the results of samples should be considered valid. If there are deviations, it is recommended to repeat the samples with another kit lot. The kits will be replaced by the manufacturer.

Manufacturer